Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cangpu decoction for atherosclerosis
ChiCTR-TRC-12002971Phase 2Completed
- Sponsor
- Tongji University
- Start
- Jan 2013
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cangpu decoction in atherosclerosis (2 arms), sponsored by Tongji University. Primary endpoints: IMT value and Grade of atherosclerotic plaque. Started Jan 2013; status: completed.
02
Drugs
cangpu decoction
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on ChiCTR-TRC-12002971.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-12002971.